Antoon A. van der Doelen

Author

Also Known As

A. A. van der Doelen, Antoon A. Van Der Doelen, Antoon A. van der Doelen, Antoon A. van der Doelen

Publications

550

Citations

H-Index

Concepts

All Affiliations

Antoon A. van der Doelen is an author at Merck (Netherlands) specializing in medicine, pharmacology, and biochemistry.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	93
2	Biochemistry	2	2	47
3	Natural Sciences	1	1	36
4	Cell Biology	1	1	46
5	Pathology	1	1	11

Antoon A. van der Doelen

Publications

550

Citations

H-Index

Page 1

	Year	Citations
3,3′,5,5′-Tetramethylbenzidine as an Ames Test Negative Chromogen for Horse-Radish Peroxidase in Enzyme-Immunoassay E. S. Bos, Antoon A. van der Doelen, N. van Rooy, Journal of Immunoassay	1981	405
Inhibition of Wnt/β-Catenin Signaling by p38 MAP Kinase Inhibitors Is Explained by Cross-Reactivity with Casein Kinase Iδ/ɛ Folkert Verkaar, Antoon A. van der Doelen, Jos F.M. Smits, Chemistry & Biology Signal TransductionSignaling PathwayMolecular PathwayMedicineCasein Kinase Iδ/ɛ	2011	46
Pharmacological Characterization of Receptor Redistribution and β-Arrestin Recruitment Assays for the Cannabinoid Receptor 1 Miranda M.C. van der Lee, Marion Blomenröhr, Antoon A. van der Doelen, SLAS DISCOVERY	2009	40
Discovery and Optimization of 1-(4-(Pyridin-2-yl)benzyl)imidazolidine-2,4-dione Derivatives As a Novel Class of Selective Cannabinoid CB2 Receptor Agonists Mario van der Stelt, Jos Cals, Silvia Broeders-Josten, Journal of Medicinal Chemistry Cannabis UseCombinatorial ChemistryMedicinal ChemistryBiochemistryFunctional Selectivity	2011	36
Discovery of Novel Small Molecule Activators of β-Catenin Signaling Folkert Verkaar, Mario van der Stelt, W. Matthijs Blankesteijn, PLoS ONE	2011	12
A novel assay for the quantitative determination of lipoprotein-X (LP-X) in serum Ebo Bos, Antoon A. van der Doelen, Ad E.H.C. Denissen, Clinica Chimica Acta Lipid AnalysisBiochemistryBioanalysisQuantitative DeterminationPathology	1983	11

Page 1